Latest News & Features
Big Pharma
The patents division of the English High Court has found that a patent owned by Genentech is invalid and denied the biotechnology company’s application for a supplementary protection certificate. 1 March 2019
Americas
The US Federal Trade Commission concluded a ten-year pay-for-delay suit yesterday, with AbbVie agreeing not to enter certain settlements in patent cases that delay market entry of generic drugs. 1 March 2019
Medtech
The US International Trade Commission has begun an investigation into whether a Danish company’s dental and orthodontic scanners and software infringed an American company’s patents. 28 February 2019
Americas
Patterson Belknap Webb & Tyler has hired Barbara Mullin, a former lawyer at Akin Gump Strauss Hauer & Feld, as special counsel. 28 February 2019
Big Pharma
A US judge has ordered Boehringer Ingelheim to release its rollout plans for a biosimilar version of Humira (adalimumab), following a request from AbbVie. 28 February 2019
Big Pharma
General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal. 28 February 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday rejected the University of Florida’s argument that its sovereign immunity protected a patent from section 101 scrutiny. 27 February 2019
Generics
A jury has upheld two of Amgen’s patents for its cholesterol drug Repatha, rejecting a challenge brought by two competitors. 26 February 2019
Americas
US-based Merck & Co has announced plans to acquire immunotherapy company Immune Design for $300 million, in a bid to strengthen its capabilities in vaccine development. 26 February 2019
Americas
Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal. 25 February 2019